共 181 条
[1]
Wei SC(2018)Fundamental mechanisms of immune checkpoint blockade therapy Cancer Discov 8 1069-1086
[2]
Duffy CR(2019)Lesion-level response dynamics to programmed cell death protein (PD-1) blockade J Clin Oncol 37 3546-3555
[3]
Allison JP(2020)Site-specific response patterns, pseudoprogression, and acquired resistance in patients with melanoma treated with ipilimumab combined with anti-PD-1 therapy Cancer-Am Cancer Soc 126 86-97
[4]
Osorio JC(2020)The agnostic role of site of metastasis in predicting outcomes in cancer patients treated with immunotherapy Vaccines 8 e203-254
[5]
Arbour KC(2019)Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy Bmc Cancer 19 857-302
[6]
Le DT(2017)Overexpression of PD-L1 and PD-L2 is associated with poor prognosis in patients with hepatocellular carcinoma Cancer Res Treat 49 246-1585
[7]
Durham JN(2016)PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer Gynecol Oncol 141 293-S1864
[8]
Plodkowski AJ(2017)Association between PD-L1 expression on tumour-infiltrating lymphocytes and overall survival in patients with gastric cancer J Cancer 8 1579-1473
[9]
Halpenny DF(2020)Programmed death ligand 1 heterogeneity and its impact on benefit from immune checkpoint inhibitors in non-small-cell lung cancer J Thorac Oncol 8 S1556-267
[10]
Silva IPD(2019)The immune landscape of esophageal cancer Cancer Commun (London, England) 39 79-1480